These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1425917)

  • 21. Antigen presentation by hapten-specific B lymphocytes. III. Analysis of the immunoglobulin-dependent pathway of antigen presentation to interleukin 1-dependent T lymphocytes.
    Rock KL; Haber SI; Liano D; Benacerraf B; Abbas AK
    Eur J Immunol; 1986 Nov; 16(11):1407-12. PubMed ID: 2946591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen presentation by cells that are not of bone marrow origin.
    Geppert TD; Lipsky PE
    Reg Immunol; 1989; 2(1):60-71. PubMed ID: 2518360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines.
    Whalen BJ; Tony HP; Parker DC
    J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
    Croft M; Swain SL
    J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The requirement for surface Ig signaling as a prerequisite for T cell:B cell interactions. A possible role for desialylation.
    Kearse KP; Cassatt DR; Kaplan AM; Cohen DA
    J Immunol; 1988 Mar; 140(6):1770-8. PubMed ID: 3126236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of antigen processing and presentation by resting B lymphocytes.
    Gosselin EJ; Tony HP; Parker DC
    J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules.
    Bartnes K; Hannestad K
    Eur J Immunol; 1997 May; 27(5):1124-30. PubMed ID: 9174601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
    St Pierre Y; Watts TH
    J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo.
    Bradley LM; Harbertson J; Biederman E; Zhang Y; Bradley SM; Linton PJ
    Eur J Immunol; 2002 Aug; 32(8):2338-46. PubMed ID: 12209647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential susceptibility of cytotoxic and helper T cell precursors to neonatal tolerization to histocompatibility antigens.
    Ishizaka ST; Carnaud C; Stutman O
    J Immunol; 1986 Oct; 137(7):2093-9. PubMed ID: 2944947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells.
    Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R
    Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells.
    Lechler RI; Norcross MA; Germain RN
    J Immunol; 1985 Nov; 135(5):2914-22. PubMed ID: 3900200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presentation of antigen by B cells subsets. I. Lyb-5+ and Lyb-5- B cells differ in ability to stimulate antigen specific T cells.
    Zimecki M; Whiteley PJ; Pierce CW; Kapp JA
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):115-23. PubMed ID: 7503644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of antigen by B cell subsets. V. Effect of interleukin 7 (IL-7) and interleukin 10 (IL-10) on phenotype and antigen presenting function of immature B cells.
    Zimecki M; Kapp JA
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):253-7. PubMed ID: 8744644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
    Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
    J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin-specific T-B cell interaction. II. T cell clones recognize the processed form of B cells' own surface immunoglobulin in the context of the major histocompatibility complex class II molecule.
    Yurin VL; Rudensky AY; Mazel SM; Blechman JM
    Eur J Immunol; 1989 Sep; 19(9):1685-91. PubMed ID: 2507327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells.
    Morrissey PJ; Bressler L; Park LS; Alpert A; Gillis S
    J Immunol; 1987 Aug; 139(4):1113-9. PubMed ID: 3038997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation.
    Carrasco-Marín E; Alvarez-Domínguez C; Leyva-Cobián F
    Eur J Immunol; 1994 Sep; 24(9):2031-9. PubMed ID: 8088323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.